Research programme: galanin receptor agonists - AstraZeneca

Drug Profile

Research programme: galanin receptor agonists - AstraZeneca

Alternative Names: Galanin-receptor-agonists-research-programme-AstraZeneca; Galnon

Latest Information Update: 14 Feb 2008

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator AstraZeneca
  • Class
  • Mechanism of Action Galanin receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Absence epilepsy

Most Recent Events

  • 05 Mar 2003 Early research in Absence seizures
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top